IF the FDA did not interfere and hold back LL the free

New Post Public Reply Private Reply Replies (0) Message Board
SizzlChest Cassandra X #79981
523
IF the FDA did not interfere and hold back LL the free market would see the tremendous benefit of Leronlimab and it would have been available to US citizens last march.


Covid crisis averted for the most part. People would know if they caught it they could recover. And herd immunity would have developed much faster.


Sorry Cassandra... the government just interferes and makes a mess out of things with layers of bureaucracy that enriches their cronies.

As far as covid being the borg... I think you meant to say the vaccines are


2

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 7

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Marketing Technology Success: Key Findings from Recent Research

Updated Category News Views 159

Discovering the Path to Martech Success In today's digital landscape, marketing technology (Martech) is a vital part of any successful business strategy. Organizations face a myriad of challenges in implementing these technologies effectively. Recent research from GNW Consulting sheds light on the factors that differentiate successful Martech initiatives from those that...

Continue Reading
Urgent Alert for Rocket Pharmaceuticals Investors: Key Details

Updated Category News Views 146

Understanding the Current Situation with Rocket Pharmaceuticals In a significant development for investors involved with Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a class action lawsuit has been initiated. This alert serves as a vital reminder for those who have invested in the company, aiming to clarify your rights and the necessary steps moving forward. Investment...

Continue Reading
Hammond Power Solutions Announces Acquisition of Micron Industries

Updated Category News Views 70

Hammond Power Solutions Announces Acquisition of Micron Industries Hammond Power Solutions Inc. (HPS) (TSX: HPS.A) has officially declared its plans to broaden its operations through a major acquisition. The company has reached a definitive agreement to acquire the assets of Micron Industries Corporation, a well-respected name in the electrical manufacturing industry....

Continue Reading
Vantive and IDBS Team Up for Advanced Organ Therapy Innovation

Updated Category News Views 151

Vantive and IDBS Team Up for Advanced Organ Therapy Innovation In a transformative move for the organ therapy sector, Vantive, a renowned company dedicated to kidney care, has forged a partnership with IDBS. This collaboration aims to revolutionize the digital landscape of vital organ therapy through advanced technology and data management capabilities. Milestone in...

Continue Reading
PSG Strengthens EdTech Landscape with New Investments

Updated Category News Views 176

PSG Strengthens EdTech Landscape with New Investments PSG, a leading growth equity firm, has made a significant move to bolster educational technology by announcing strategic investments in two key software companies. These companies, Verity IQ and Campus Ivy, are focused on improving educational environments. Verity IQ is recognized for its customer relationship...

Continue Reading